Even Distribution of Protective Hemoglobin Prevents Sickle Cell Symptoms
Versiti Blood Research Institute posted on LinkedIn:
”New research from VBRI investigator Phillip Doerfler uncovers new insights into sickle cell disease protection: uniform expression of fetal hemoglobin matters as much as its quantity.
Doerfler and colleagues from St. Jude Children’s Research Hospital, Christian Medical College Vellore, and University of Minnesota used single-cell RNA sequencing to examine blood cells from patients with two genetic variations that increase fetal hemoglobin, a protein that prevents sickling.
Patients whose cells expressed fetal hemoglobin consistently had no sickle cell symptoms. Patients with dramatic variation (some cells carrying high levels, others with very little) suffered pain crises and acute chest syndrome despite similar average hemoglobin percentages.
The difference is immense. Traditional tests measure what percentage of cells express fetal hemoglobin, but cannot detect how much each cell produces. How can we know whether a patient is protected?
The discovery offers crucial guidance for gene therapy approaches that reactivate fetal hemoglobin. Consistency of expression across the cell population may predict clinical benefit better than average levels alone.
Read the article in Blood Journals Portfolio’s Blood.
Advances here.”
Title: Single-cell transcriptomics reveals heterocellular g-globin gene expression in Agdb-thalassemia
Authors: Phillip A Doerfler, Yichao Li, Yu Yao, Ruopeng Feng, Thiyagaraj Mayuranathan, Jingjing Zhang, Emilia Kooienga, David Cullins, Rohith Jesudas, Dillon C Williams, Jane S Hankins, Yong Cheng, David K Wood, Mitchell J. Weiss
Stay updated with Hemostasis Today.
-
Nov 8, 2026, 12:22Marc Carrier: Advancing Catheter-Related Thrombosis Prevention Through Factor XI Inhibition
-
Nov 8, 2026, 11:56Why Genetic Predisposition Does Not Always Lead to Thrombosis – Stork Genetics
-
Nov 8, 2026, 11:45Sher-Lu Pai: Investigating Intracardiac Thrombosis and Its Management in Liver Transplantation
-
Nov 8, 2026, 11:25Mehmet Cilingiroglu: Navigating Anticoagulation Choices in Acute Coronary Syndrome PCI
-
Nov 8, 2026, 07:16Gilberto de lima Lopes Junior: The Cardiovascular Consequences of Cancer in Younger Patients
-
Nov 8, 2026, 06:51Haney Mallemat: Key Principles and Pitfalls of LVAD Emergencies
-
Nov 8, 2026, 06:31Maria Omer: Clinical Recognition and Management of Cavernous Sinus Thrombosis
-
Nov 8, 2026, 06:16Natasha Jolakoski: University of New Mexico Hospital Promotes PGY-2 Thrombosis and Hemostasis Management Pharmacy Residency
-
Nov 8, 2026, 05:47Safaa Hilal: POCUS in the Evaluation of Perioperative Troponin Elevation